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Summary
Objective: To establish the role of hypoxia and HIF-1 for VEGF expression of murine epiphyseal chondrocytes. To analyze the effect of
hypoxia on VEGF isoform expression.
Materials and Methods: VEGF mRNA and VEGF isoform expression was investigated in epiphyses of murine newborns by in situ
hybridization and real-time PCR. Further, epiphyseal chondrocytes were isolated from newborn mice with homozygous flanking of the HIF-1
gene with lox-P sites. HIF-1 was deleted by infection with adenovirus containing cre-recombinase. After chondrocytes reached confluency
they were exposed to 0.5% or 20% oxygen, respectively. Total VEGF and VEGF isoform mRNA expression levels were measured by
real-time PCR. Secreted VEGF protein was determined by ELISA.
Results: VEGF mRNA signals were detected in the hypertophic zone and in the center of the proliferative zone of the murine epiphysis, which
is considered to be hypoxic. Real-time PCR revealed that VEGF120 is the dominant isoform in vivo. In cultured epiphyseal chondrocytes
strongly increased VEGF gene expression levels were detected after exposure to hypoxia. Furthermore, secretion of VEGF protein was
significantly enhanced under 0.5% oxygen. Remarkably, functional inactivation of HIF-1 abolished the hypoxic increase of VEGF
expression in chondrocytes completely. Furthermore, the soluble isoforms VEGF120 and VEGF164 are the most abundantly expressed splice
variants in chondrocytes exposed to low oxygen levels.
Conclusions: The data presented here clearly indicate that hypoxia is able to induce the synthesis of soluble VEGF isoforms by epiphyseal
chondrocytes, most likely through stabilization of HIF-1. Thus it can be speculated that HIF-1 is an essential prerequisite for hypoxic VEGF
synthesis in the epiphysis, thereby contributing to the formation and invasion of blood vessels in long bone development.
© 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Introduction
Endochondral ossification at the epiphyseal growth plate is
the key mechanism in long bone development. The pro-
cess of endochondral ossification is characterized by a
series of well defined temporally and spatially controlled
events leading to the longitudinal growth of bones. During
this complex process epiphyseal chondrocytes undergo
proliferation, differentiation and hypertrophy1,2. At the
chondro-osseous border hypertrophic chondrocytes miner-
alize the cartilaginous matrix by liberating matrix vesicles
and eventually undergo programmed cell death3–5. Finally,
the mineralized matrix at the chondro-osseous junction is
resorped and replaced by bone. This replacement process
of calcified cartilage is accompanied by formation and
invasion of blood vessels from the metaphyseal bone6.
Chondrocyte proliferation, differentiation and apoptosis are
strictly limited to their respective zones and tightly regu-
lated by a diverse range of control mechanisms. Specifi-
cally, angiogenesis at the primary ossification center is
considered to be balanced by several pro-angiogenic and
anti-angiogenic factors, e.g. matrix molecules as well as
matricryptic sites within matrix molecules, growth factors
and microenvironmental conditions like partial oxygen
pressure, lactate concentration and local pH7–9. Among the
group of pro-angiogenic molecules, vascular endothelial
growth factor (VEGF) is one of the most potent members
characterized to date10,11. VEGF is a dimeric glycoprotein
with a molecular weight between 17 and 22 kDa under
reducing conditions. The VEGF gene product is differen-
tially spliced into four common and three rare isoforms that
vary from 121 to 206 amino acids in humans12. However, in
mice only three VEGF isoforms have been described thus
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far: VEGF120, VEGF164 and VEGF188 (one amino acid
shorter than their human counterparts)13. VEGF188 is
sequestered to the cell surface by tight interaction with
heparan-sulfate proteoglycans and can therefore not be
detected in the supernantant of VEGF188 producing cells11.
Biological activity of VEGF188 is detectable only after
release from its binding sites by the action of certain
proteases14. However, the two soluble isoforms, VEGF120
and VEGF164, are able to deliver instantaneous pro-
angiogenic signals to their target structures15. VEGF has
been shown to be centrally involved in numerous physio-
logical and pathological processes, such as development,
inflammation and tumorigenesis16–18. Areas of low oxygen
partial pressure (hypoxia) are commonly found in all these
states and VEGF synthesis is increased several fold by
hypoxia. The main mediator of the increased VEGF expres-
sion by low oxygen levels is the transcription factor
hypoxia-inducible factor-1 (HIF-1), consisting of two sub-
units HIF-1 and HIF-119. HIF-1 binds to a 5′ consensus
sequence termed hypoxia responsive element (HRE) in the
VEGF promoter, thereby initiating its expression20. How-
ever, hypoxia stimulates the expression of all VEGF iso-
forms, but angiogenic signals are mainly mediated by the
soluble isoforms, binding to the cell surface receptors
VEGFR1 (Flt-1) and VEGFR2 (Flk-1/KDR) of the respec-
tive target cells11. Previous studies have clearly shown that
VEGF is expressed by hypertrophic chondrocytes mediat-
ing capillary invasion and eventually growth plate
morphogenesis21–23. In additition to its effects on vessels
VEGF seems to be an essential coordinator of chondrocyte
death and extracellular matrix remodeling by functional
activation of chondrocytes, chondroclasts and osteo-
blasts21. In a previous study we have provided in vivo
evidence that the growth plate is hypoxic and cell growth
and cell survival are critically depending on HIF-124. In
addition to these data, we have clearly shown that HIF-1
is indispensable for chondrocytic energy generation and
matrix synthesis (aggrecan, type II collagen), specifically in
hypoxic microenvironments25. In the present study we have
further characterized the effect of hypoxia and normoxia on
VEGF synthesis, with special emphasize on the soluble
isoforms 120 and 164. Furthermore, we have determined
the role of HIF-1 in the regulation of VEGF isoform
expression in vitro.
Materials and methods
IN SITU HYBRIDIZATION
Hindlimbs from neonatal mice were fixed in 10% buffered
formalin followed by dehydration and paraffin embedding.
Tissue blocks were cut in 5 µm slides. Complementary
(35S)UTP-labeled mouse VEGF riboprobe was used for in
situ hybridizations. The antisense probe was synthesized
from a linearized plasmid kindly provided by Dr B. Olsen
(Harvard Medical School). In situ hybridization was con-
ducted as previously described24. Briefly, bone sections
were deparaffinized in xylene and rehydrated in a decreas-
ing ethanol series (100%, 90% and 70%). After proteinase
K treatment and postfixation in 4% PFA, sections were
incubated in 0.2N HCL. Sections were then acetylated
with 0.25% acetic anhydride in triethanolamine buffer,
dehydrated in ethanol and air-dried. Sections were hybrid-
ized with 35S-labeled antisense riboprobe in a humidified
chamber at 50° for 16 h. After hybridization, unspecifically
bound riboprobes were removed by sequential washes with
graded stringency, following which slides were dipped in
photoemulsion and exposed at 4°. After developing, slides
were counterstained with hematoxylin-eosin and analyzed
with a Zeiss microscope (Zeiss, Jena, Germany).
CHONDROCYTE ISOLATION AND CULTURE
Epiphyseal chondrocytes were isolated from newborn
mice as described25. We used specific mice which dis-
played homozygous flanking of the HIF-1 gene locus
(exon 2) by lox-P sites as described detailed previously7.
In brief, forelimbs and hindlimbs were dissected, hands,
skin and particularly muscles removed. The epiphyses
were micro-dissected and placed in HBSS (Gibco BRL).
Epiphyses were digested in 0.25% trypsin containing EDTA
for 30 min at 37° (without Ca2+ and Mg2+) and collagenase
195 Units/ml HBSS (Worthington). Chondrocytes were
plated at a density of 4×105 cells per well of 6-well-plates
and grown in monolayer cultures in high glucose DMEM
(Gibco BRL), supplemented with 5% FCS (Hyclone) and
1% penicillin/streptomycin. At day 1 post-plating, adherent
chondrocytes were infected with adenovirus (MOI 100)
containing either beta-galactosidase or cre recombinase to
create wild-type chondrocytes (+/+) or HIF-1 deleted cells
(−/−) as described in detail previously25. After incubation for
24 h, deletion frequency of the HIF-1 gene was deter-
mined by TaqMan-PCR (∼74%). After chondrocytes
reached confluency (day 5 post-plating), cells were cul-
tured either with 0.5% or 20% oxygen, balanced with N2 in
a 3-Gas incubator (Sanyo) in a humidified atmosphere.
During all experiments medium was changed daily.
RNA-ISOLATION AND REVERSE TRANSCRIPTION
Chondrocytes were lysed by addition of RNA-Bee
(Tel-Test Inc.) directly to the 6-well plates. Cell-lysate was
scraped and carefully pipetted into a tube. After supple-
mentation of bromochloropropane tubes were centrifuged
at 14.000 g for 10 min at 4°C. After carefully pipetting the
aqueous phase, RNA was precipitated with isopropanol.
After a 13.000 g spin, the RNA pellet was washed in 70%
ethanol. RNA yield was determined spectrophotometrically.
A digestion step with DNAse I (Gibo BRL) was introduced
to avoid interference of genomic DNA with the PCR
reactions. For reverse transcription the Superscript First-
Strand Synthesis System for RT-PCR (Gibco BRL) with
random hexamer primers was used according to the manu-
facturer’s instructions. For total RNA isolation from epi-
physeal cartilage, forelimbs and hindlimbs from newborn
wild-type mice were dissected. Hands, skin and particularly
muscles were removed. The epiphyses were micro-
dissected under a microscope and minced in liquid nitro-
gen. Tissues were homogenized in RNA-Bee (Tel-Test Inc.)
and total RNA was isolated according to the manufacturer’s
instructions.
REAL-TIME PCR
For PCR analyses cDNAs from triplicate wells of three
independent experiments (22 h hypoxia or normoxia) or six
newborns were diluted to a final concentration of 10 ng/µl.
For PCR reactions SYBR-Green Mastermix (Applied Bio-
sytems) was used. 50 ng total cDNA was used as template
to determine the relative amount of mRNA by real-time
PCR (ABI Prism 7700 sequence detection system) using
specific primers. The reaction was conducted as follows:
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95°C for 4 min, and 40 cycles of 15 s 95°C and 1 min 60°C.
-actin was amplified as an internal control. Cycle treshold
(Ct) values were measured and calculated by the Se-
quence detector software. Relative amounts of mRNA
were normalized to -actin and calculated with the soft-
ware program Microsoft Excel. Relative mRNA contents
were calculated as x=2−Ct in which Ct=E−C and
E=Ctsample−Ct-actin and C=Ctcontrol−Ct-actin. Primers for
total VEGF and -actin were designed using the ‘Primer
design’ software by Perkin Elmer. The following sequences
were used: total VEGF forward GCC AGC ACA TAG AGA
GAA TGA GC, total VEGF reverse ATC CGC ATG ATC
TGC ATG G, -actin forward AGG CCC AGA GCA AGA
GAG G, -actin reverse TAC ATG GCT GGG GTG TTG AA.
To determine the relative expression of VEGF isoforms we
used primer pairs elegantly designed by Zhang et al.26. In
order to be able to calculate the relative amount of VEGF
isoforms compared to the expression of total VEGF, the
amplification efficiency of the four different PCR reactions
(VEGF total, VEGF120, VEGF164, VEGF188) was deter-
mined. Analysis of 6 serial 1:5 dilutions of a defined
template cDNA demonstrated a 98% identical efficiency of
the four different PCR reactions (data not shown).
VEGF-ELISA
Protein concentrations of soluble VEGF isoforms were
determined using the DuoSet ELISA development KIT for
mouse VEGF (R&D Systems). Cell culture supernatants
(wild type and HIF-1 null cells) from triplicates of three
different experiments were harvested after exposure to
either 22 h normoxia or hypoxia, centrifuged with 12.000 g
and stored at −20°C. Further VEGF-ELISA was conducted
according to the manufacturer’s instructions. Total protein
in supernatants was measured using the Bradford assay
(Biorad) and VEGF levels were expressed normalized to
protein content.
Results
In the first set of our experiments we analyzed the
expression pattern of VEGF mRNA within the epiphysis by
in situ hybridization. We detected specific signals in the
hypertrophic zone (arrowheads) and to a lower extend in
the center of the proliferative zone (arrows) which is con-
sidered to be hypoxic (Fig. 1A, B)24,28,29. In order to
quantify different VEGF isoforms total RNA was extracted
from epiphyseal cartilage of newborn mice. Subsequent
real-time PCR analysis revealed that the soluble isoform
VEGF120 is the most abundant isoform in epiphyseal carti-
lage with 48% of total VEGF mRNA (Fig. 1C). Furthermore,
soluble VEGF164 was strongly expressed in the epiphysis
of newborn mice. In contrast cell bound VEGF188 displayed
low expression levels, constituting only 11% of total VEGF
mRNA. However, the remaining 14% of total VEGF mRNA
might represent alternative splicing products.
Next, we isolated epiphyseal chondrocytes of murine
newborns and cultured them for subsequent in vitro analy-
sis. The second exon of the HIF-1  gene locus of these
chondrocytes was flanked by lox-P sites, as described in
detail previously27. By infection with adenovirus expressing
either -galactosidase or cre recombinase we created
wild-type chondrocytes (+/+) or HIF-1 deleted cells (−/−).
After chondrocytes reached confluency (∼day 5 post-
plating), cells were cultured under 0.5 or 20% oxygen for
22 h.
We proceeded by analyzing expression of total VEGF by
quantitative real-time PCR. We determined a 9.5-fold
increase of VEGF mRNA levels in wild-type chondro-
cytes under hypoxic conditions compared to normoxia. In
addition, we found that this increase in VEGF expression
under 0.5% oxygen was completely abolished in chondro-
cytes with cre-mediated deletion of HIF-1 (Fig. 2A).
Next, we analyzed protein levels of the soluble VEGF
isoforms 120 and 164 in cell culture supernatants by ELISA
after exposure to 22 h of hypoxia or normoxia. As shown in
Fig. 2B, we detected significantly higher protein levels in
the hypoxic cultures compared to normoxic wild-type cul-
tures. HIF-1 null chondrocytes failed to upregulate VEGF
protein secretion in response to hypoxia, thereby mirroring
the above outlined gene expression analysis (Fig. 2B).
We continued our study by analysis of chondrocyte gene
expression of VEGF120, VEGF164 and VEGF188 with real-
time PCR using isoform specific primers. Interestingly, the
highest increase in mRNA expression under hypoxia was
detected for the 164 aminoacid isoform; 13.3-fold of control
chondrocytes cultured under 20% oxygen (Fig. 3A). How-
ever, VEGF120 (11.0-fold) and VEGF188 (10.0-fold) mRNA
expression levels were increased to a lesser extent after
exposure to hypoxic conditions (Fig. 3B and C). Further-
more, we found that expression of all VEGF isoforms
during extremely low levels of oxygen is dependent on the
presence of HIF-1.
Finally, we determined the relative contribution of each
isoform to total VEGF mRNA expression by quantitative
real-time PCR. As demonstrated in Fig. 4, we obtained
comparable results from normoxic (Fig. 4A) and hypoxic
(Fig. 4B) chondrocyte cultures. VEGF120 was the dominant
isoform in wild-type as well as HIF-1 null chondrocytes in
the presence and absence of oxygen. However, the relative
amount of VEGF164 mRNA increased under hypoxic con-
ditions. In summary, VEGF isoform expression in vitro was
mirroring the pattern in vivo (Fig. 1B).
Discussion
It has been previously demonstrated by us and other
independent groups that the growth plate is characterized
by hostile microenvironmental conditions such as hypoxia
and acidosis24,28,29. Specifically, we and other groups have
provided evidence that the upper hypertrophic zone and
the central portion of the proliferative zone are exposed
to low oxygen tensions24,28. In addition, we have shown
that the transcription factor HIF-1 is required for proper
adaptation of chondrocytes to these demanding conditions,
ultimately controlling cell survival and functional cartilage
integrity24,25. Beside its effects on anaerobic energy
generation, HIF-1 is of key importance for the transcription
of VEGF, one of the most potent inducers of angiogenesis
and vascular permeability. Here we have demonstrated
for the first time that VEGF isoforms are differentially
expressed in murine epiphyseal chondrocytes in vivo and
during hypoxia in vitro and that this expression is depen-
dent on HIF-1. Cells which release soluble VEGF isoforms
are able to induce the formation and invasion of blood
vessels in surrounding tissues30. Within the growth plate,
VEGF expression is mainly detected in the hypertrophic
zone next to the chondro-osseous junction where the first
vessels of long bones are formed. Beside its effects on
angiogenesis Gerber et al. have suggested that VEGF and
the newly formed blood vessels are involved in the terminal
differentiation process eventually followed by apoptosis of
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chondrocytes21. In this study we have confirmed the
results of previous work showing expression of VEGF in
the hypertrophic zone and to a lesser extend in the
central proliferative zone which has been shown to be
hypoxic24,31. In addition, we have clearly shown in vivo that
the soluble isoforms VEGF120 and VEGF164 are expressed
to a much higher degree then cell bound VEGF188. This
led us to investigate whether the regulation of VEGF
expression under low oxygen tensions is dependent on
HIF-1, as reported for other tissue types. The results of
our analysis clearly demonstrate that VEGF gene and
protein expression during hypoxia are indeed HIF-1
dependent. However, the basal VEGF gene transcrip-
tion seems to be regulated by a HIF-1 independent
mechanism. Thus, in view of the hypoxic inner growth
plate, it is reasonable to hypothesize that VEGF expression
of epiphyseal chondrocytes in the hypoxic center is regu-
lated by the oxygenation status. Next, we analyzed the
differential expression of VEGF isoforms with respect to
oxygen partial pressure. Hypoxia significantly induced the
expression of the three investigated VEGF isoforms. This
significant increase in VEGF mRNA expressions was com-
pletely lost in HIF-1 null cells. Furthermore we have
shown that relative mRNA expression patterns (compared
to total VEGF expression) of the three investigated VEGF
isoforms were nearly similar in wild-type or HIF-1 null
chondrocytes during 0.5% and 20% oxygen. This obser-
vation is not surprising, since HIF-1 has been shown to
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Fig. 1. VEGF mRNA expression in the growth plate. In situ hybridization analysis of distal femur growth plate sections with the VEGF
antisense probe, H&E counterstain. Resting zone (RZ), proliferative zone (PZ) and hypertrophic zone (HZ) are labeled. Brightfield (A) and
darkfield (B) images are shown. Areas of VEGF mRNA expression were detected within the hypertrophic zone (indicated by arrowheads) and
to a lesser extent in the central proliferative zone (indicated by arrows). VEGF gene expression in cartilage RNA from newborn wild-type mice
was analyzed by quantitative real-time PCR (C). Bars are representing relative amounts of VEGF isoforms compared to total VEGF mRNA,
which was defined as 1. Data are given as mean±SD (triplicates from three independent experiments).
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initiate the transcription process, but not the alternative
splicing of the respective isoforms. Additionally, we have
clearly shown that soluble isoforms VEGF120 and VEGF164
are the most abundantly expressed isoforms in vivo and
under low oxygen tension in vitro. This observation is in
good accordance with previous studies, which have
analyzed long bone development in mice expressing only
the VEGF120 isoform31,32. In these mice the recruitment
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Fig. 2. VEGF mRNA expression and protein secretion by wild-type
and HIF-1 deficient chondrocytes under normoxia and hypoxia.
Chondrocytes were exposed to either 0.5% or 21% oxygen for
22 h and VEGF gene expression levels analyzed by quantitative
real-time PCR (A). Bars are representing the several-fold changes
in VEGF mRNA levels of wild-type (WT) and HIF-1 null chondro-
cytes exposed to 0.5% and 21% oxygen under normoxia (nor-
moxic wild type levels were taken as 1). Data are given as
mean±SD (triplicates from three independent experiments). Statisti-
cal differences were calculated with the unpaired Student’s t-test;
**P≤0.01. Soluble VEGF isoforms (VEGF 120 and 164) were
analyzed by ELISA in conditioned medium of wild-type (WT) and
mutant chondrocytes after 22 h exposure to either hypoxia or
normoxia (B). Bars are representing the means±SD of triplicates
from three independent experiments, normalized to total protein
concentrations. Statistical differences were calculated with the
unpaired Student’s t-test; **P≤0.01.
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Fig. 3. Real-time PCR for VEGF isoform expression
(VEGF120,164,188) by wild-type (+/+) and HIF-1 null (−/−) chondro-
cytes. Chondrocytes were exposed to either 0.5% or 21% oxygen
for 22 h. Bars are representing the several-fold changes of differ-
ent VEGF isoforms expression levels of wild-type (WT) and HIF-1
null chondrocytes exposed to 0.5% and 21% oxygen (normoxic
wild type levels were taken as 1). Panels A VEGF120; B VEGF164;
C VEGF188. Data are given as mean±SD (triplicates from three
independent experiments). Statistical differences were calculated
with the unpaired Student’s t-test; **P≤0.01.
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and invasion of blood vessels were strongly delayed,
suggesting the importance of both soluble isoforms, able to
deliver pro-angiogenic signals to the target structures. On
the other hand, it has been shown that human oxidized
VEGF isoforms 121 and 165 loose their ability to bind
VEGF-receptor 2, which is required for metaphyseal vas-
culogenesis and expressed within the growth plate33,34.
Binding of cell-surface heparan-sulfate proteoglycans can
restore the binding ability of the 165 isoform, but not of the
121 isoform. This observation may explain, why VEGF121
was reported to have less mitogenic potential than
VEGF165 (in human cells). Thus we present the novel and
interesting finding that murine VEGF120 and VEGF164 are
the dominant isoforms in epiphyseal chondrocytes cultured
under extremely low oxygen levels. In addition, our data
provide evidence for a role of HIF-1 in triggering chondro-
cytic VEGF expression under normoxic conditions. In
summary, we have shown that hypoxia is able to induce
the synthesis of soluble VEGF isoforms by epiphyseal
chondrocytes most likely through stabilization of HIF-1.
Thus it can be speculated that HIF-1 is a prerequisite for
hypoxic and partly normoxic VEGF synthesis in the epiphy-
sis, thereby contributing to the formation and invasion of
blood vessels in long bone development.
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